Trevor R. Scott

Statistics

Publications

Citations

800

H-Index

Active since

1987

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

GlaxoSmithKline (United Kingdom)

Johns Hopkins University

United States Army Medical Research Directorate - Africa

Trevor R. Scott is an author at GlaxoSmithKline (United States) specializing in pharmacology, clinical pharmacology, and infectious disease pharmacotherapy.

Publications per year

1987–2006

Publications

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations

Arlene R. Hughes, Michael Mosteller, Aruna T. Bansal et al. · Pharmacogenomics · 2004 · 255 citations

Life Sciences, Genetics, Immunology +15

Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected Adults

Edwin DeJesus, Gisela Herrera, Eugénio Teófilo et al. · Clinical Infectious Diseases · 2004 · 226 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Abacavir Once or Twice Daily Combined With Once-Daily Lamivudine and Efavirenz for the Treatment of Antiretroviral-Naive HIV-Infected Adults

Graeme Moyle, Edwin DeJesus, Pedro Cahn et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 119 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results

Angela D. M. Kashuba, Camlin Tierney, Gerald Downey et al. · AIDS · 2005 · 55 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Atovaquone and Proguanil Hydrochloride for Prophylaxis of Malaria

G. Dennis Shanks, Peter G. Kremsner, T Y Sukwa et al. · Journal of Travel Medicine · 1999 · 39 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 10